Evidence map›Paper›PMID 34232478›Full record

ArticleClinical drug investigation2021

Establishing and Evaluating a Study Questionnaire on Knowledge and Attitudes of Healthcare Professionals Towards Recreational and Medical Cannabis Across Europe.

Emilie Jouanjus, Carla Sans-Pola, Beatrice Mainoli, Farideh A Javid, Isabella Ekheden, Working Group on Medical Cannabis Projects of the EACPT Young Clinical Pharmacologists

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Clinical drug investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 5 countries.

Emilie JouanjusCenter for Epidemiology and Research in POPulation health (CERPOP), Team EQUITY, UMR Inserm-University of Toulouse, University of Toulouse III Paul Sabatier, Faculty of Medicine, 37 Allées Jules Guesde, 31000, Toulouse, France. emilie.jouanjus@univ-tlse3.fr.ORCID http://orcid.org/0000-0002-3510-2475
Carla Sans-PolaClinical Pharmacology service, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5834-3183
Beatrice MainoliLaboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.ORCID http://orcid.org/0000-0002-5295-4346
Farideh A JavidDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.ORCID http://orcid.org/0000-0002-2775-6276
Isabella EkhedenClinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-0445-6630
Working Group on Medical Cannabis Projects of the EACPT Young Clinical Pharmacologists
Karolinska University Hospital · SEUniversitat Autònoma de Barcelona · ESUniversité Toulouse III - Paul Sabatier · FRUniversity of Huddersfield · GBUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveThe present survey was a preliminary to a European research project on the attitude and knowledge of healthcare professionals towards the use of medical cannabis. The objective was to evaluate the readability, understandability, and relevance of a first version of the study questionnaire before preparing the finalized questionnaire, which will be subsequently proposed to European healthcare professionals on a large scale.

methodsA cross-sectional study was conducted between December 2019 and May 2020. We established an electronic evaluation questionnaire relating to the study questionnaire. This evaluation questionnaire was proposed to multidisciplinary experts from all over Europe. Feedback from the evaluation questionnaire was considered for improving and finalizing the study questionnaire.

results66 evaluation questionnaires were collected from nine European countries (Cyprus, France, Germany, Italy, Lithuania, Portugal, Spain, Sweden, United Kingdom), which corresponded to a participation rate of 41.5%. Most participants were women (65.2%, n = 43). The mean age was 39.5 years ± 11.6. Each participant could specify several occupations. There were 25 pharmacologists, 24 physicians, ten pharmacists, four university teachers, three epidemiologists or public health experts, one nurse, one biotechnologist, one microbiologist, and one police researcher. Overall, 84.8% of participants were interested in the topic of the survey on the knowledge and attitudes of healthcare professionals towards recreational and medical cannabis across Europe. Participants were satisfied with all but six of the proposed questions. In addition, two additional questions were subject for comments despite a high level of satisfaction. Consequently, the concerned questions (n = 8) were modified.

conclusionThis evaluation survey was a necessary step to improve the quality of the future research project. The positive feedback encourages the authors to proceed with the project on a European scale, scheduled for 2021.

Indexed as

Medical MarijuanaAdultAttitudeCross-Sectional StudiesDelivery of Health CareEuropeFemaleHealth Knowledge, Attitudes, PracticeHumansSurveys and QuestionnairesMedical Marijuana

Identifiers

PMID34232478
OpenAlexW3182537414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.